BIIB
Price
$132.15
Change
-$0.50 (-0.38%)
Updated
Aug 29, 04:59 PM (EDT)
Capitalization
19.45B
54 days until earnings call
SCLX
Price
$17.97
Change
-$0.26 (-1.43%)
Updated
Aug 29, 04:15 PM (EDT)
Capitalization
126.8M
Interact to see
Advertisement

BIIB vs SCLX

Header iconBIIB vs SCLX Comparison
Open Charts BIIB vs SCLXBanner chart's image
Biogen
Price$132.15
Change-$0.50 (-0.38%)
Volume$20.76K
Capitalization19.45B
Scilex Holding
Price$17.97
Change-$0.26 (-1.43%)
Volume$100
Capitalization126.8M
BIIB vs SCLX Comparison Chart in %
Loading...
BIIB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIIB vs. SCLX commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIIB is a StrongBuy and SCLX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (BIIB: $132.65 vs. SCLX: $18.23)
Brand notoriety: BIIB: Notable vs. SCLX: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: BIIB: 113% vs. SCLX: 50%
Market capitalization -- BIIB: $19.45B vs. SCLX: $126.8M
BIIB [@Pharmaceuticals: Major] is valued at $19.45B. SCLX’s [@Pharmaceuticals: Major] market capitalization is $126.8M. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $656.17B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $88.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIIB’s FA Score shows that 0 FA rating(s) are green whileSCLX’s FA Score has 0 green FA rating(s).

  • BIIB’s FA Score: 0 green, 5 red.
  • SCLX’s FA Score: 0 green, 5 red.
According to our system of comparison, SCLX is a better buy in the long-term than BIIB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIIB’s TA Score shows that 4 TA indicator(s) are bullish while SCLX’s TA Score has 3 bullish TA indicator(s).

  • BIIB’s TA Score: 4 bullish, 5 bearish.
  • SCLX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, SCLX is a better buy in the short-term than BIIB.

Price Growth

BIIB (@Pharmaceuticals: Major) experienced а -4.65% price change this week, while SCLX (@Pharmaceuticals: Major) price change was +6.36% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.84%. For the same industry, the average monthly price growth was +1.29%, and the average quarterly price growth was +11.90%.

Reported Earning Dates

BIIB is expected to report earnings on Oct 22, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.84% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BIIB($19.4B) has a higher market cap than SCLX($127M). SCLX YTD gains are higher at: 22.152 vs. BIIB (-13.255). BIIB has higher annual earnings (EBITDA): 2.79B vs. SCLX (-70.91M). BIIB has more cash in the bank: 2.76B vs. SCLX (4.1M). SCLX has less debt than BIIB: SCLX (41.8M) vs BIIB (6.6B). BIIB has higher revenues than SCLX: BIIB (10B) vs SCLX (44.2M).
BIIBSCLXBIIB / SCLX
Capitalization19.4B127M15,276%
EBITDA2.79B-70.91M-3,940%
Gain YTD-13.25522.152-60%
P/E Ratio12.69N/A-
Revenue10B44.2M22,618%
Total Cash2.76B4.1M67,309%
Total Debt6.6B41.8M15,778%
FUNDAMENTALS RATINGS
BIIB: Fundamental Ratings
BIIB
OUTLOOK RATING
1..100
16
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BIIBSCLX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
38%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
47%
Momentum
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
44%
MACD
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
43%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
47%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
36%
Advances
ODDS (%)
Bullish Trend 8 days ago
53%
Bullish Trend 12 days ago
71%
Declines
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
40%
Aroon
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
25%
View a ticker or compare two or three
Interact to see
Advertisement
BIIB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BULZ201.634.90
+2.49%
MicroSectors™ Slct FANG Inn 3X Lvgd ETNs
BEGS34.510.07
+0.22%
Rareview 2X Bull Cryptoccy & Prc Mtl ETF
JULW38.030.07
+0.19%
AllianzIM US Large Cap Buffer20 Jul ETF
BUL53.080.08
+0.14%
Pacer US Cash Cows Growth ETF
BEEZ33.680.01
+0.04%
Honeytree U.S. Equity ETF

SCLX and

Correlation & Price change

A.I.dvisor tells us that SCLX and BIIB have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SCLX and BIIB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCLX
1D Price
Change %
SCLX100%
+1.17%
BIIB - SCLX
20%
Poorly correlated
-2.72%
AMRN - SCLX
20%
Poorly correlated
-0.42%
SNY - SCLX
9%
Poorly correlated
-0.34%
ABBV - SCLX
8%
Poorly correlated
-0.07%
RHHVF - SCLX
8%
Poorly correlated
-1.80%
More